OS Therapies Incorporated (OSTX)
NYSEAMERICAN: OSTX · Real-Time Price · USD
3.970
+0.060 (1.53%)
At close: Dec 20, 2024, 4:00 PM
3.790
-0.180 (-4.53%)
After-hours: Dec 20, 2024, 7:20 PM EST

OS Therapies Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20
Cost of Revenue
0.010.0101.164.25
Gross Profit
-0.01-0.01-0-1.16-4.25
Selling, General & Admin
2.011.121.151.50.8
Research & Development
2.993.223.292.170.6
Operating Expenses
54.344.453.681.4
Operating Income
-5-4.34-4.45-4.84-5.65
Interest Expense
-2.35-3.45-1.81-2.58-0.46
Interest & Investment Income
00--0.06
Other Non Operating Income (Expenses)
----0.02
Pretax Income
-7.36-7.79-6.25-7.42-6.03
Net Income
-7.36-7.79-6.25-7.42-6.03
Preferred Dividends & Other Adjustments
0.060.130.130.09-
Net Income to Common
-7.42-7.92-6.38-7.51-6.03
Shares Outstanding (Basic)
101110108
Shares Outstanding (Diluted)
101110108
Shares Change (YoY)
-6.42%7.01%-18.50%-
EPS (Basic)
-0.76-0.74-0.64-0.75-0.72
EPS (Diluted)
-0.76-0.74-0.64-0.75-0.72
Free Cash Flow
-5.78-3.01-3.79-4.41-2.42
Free Cash Flow Per Share
-0.59-0.28-0.38-0.44-0.29
EBITDA
-5-4.34-4.45-4.84-5.65
D&A For EBITDA
00000
EBIT
-5-4.34-4.45-4.84-5.65
Source: S&P Capital IQ. Standard template. Financial Sources.